G. L. Christensen

发表

β‐Arrestin 1 and 2 stabilize the angiotensin II type I receptor in distinct high‐affinity conformations

S. Gammeltoft, S. J. Sanni, J. L. Hansen, 2010, British journal of pharmacology.

Functionally Selective AT1 Receptor Activation Reduces Ischemia Reperfusion Injury

J. L. Hansen, Bo Liang, T. Jespersen, 2012, Cellular Physiology and Biochemistry.

Pre-treatment of blood samples reveal normal blood hypocretin/orexin signal in narcolepsy type 1

G. Plazzi, P. Jennum, N. Jørgensen, 2021, Brain communications.

Bone turnover markers are differentially affected by pre-analytical handling

N. Jørgensen, G. L. Christensen, J. R. Halgreen, 2019, Osteoporosis International.

Therapeutic potential of functional selectivity in the treatment of heart failure.

J. L. Hansen, M. Aplin, G. L. Christensen, 2010, Trends in cardiovascular medicine.

Pharmacologic perspectives of functional selectivity by the angiotensin II type 1 receptor.

J. L. Hansen, M. Aplin, G. L. Christensen, 2008, Trends in cardiovascular medicine.

Differential extracellular signal-regulated kinases 1 and 2 activation by the angiotensin type 1 receptor supports distinct phenotypes of cardiac myocytes.

S. Gammeltoft, J. L. Hansen, A. Heydorn, 2007, Basic & clinical pharmacology & toxicology.

The angiotensin type 1 receptor activates extracellular signal-regulated kinases 1 and 2 by G protein-dependent and -independent pathways in cardiac myocytes and langendorff-perfused hearts.

S. Gammeltoft, J. L. Hansen, A. Heydorn, 2007, Basic & clinical pharmacology & toxicology.

Bone morphogenetic protein 4 inhibits insulin secretion from rodent beta cells through regulation of calbindin1 expression and reduced voltage-dependent calcium currents

L. Eliasson, N. Billestrup, A. Wendt, 2015, Diabetologia.

The human angiotensin AT(1) receptor supports G protein-independent extracellular signal-regulated kinase 1/2 activation and cellular proliferation.

D. Weiner, J. L. Hansen, S. Haunsø, 2008, European Journal of Pharmacology.

Repeated measures of hypocretin-1 in Danish and Italian patients with narcolepsy and in controls.

E. Mignot, G. Plazzi, P. Jennum, 2022, Sleep medicine.

A new MCF-7 breast cancer cell line resistant to the arzoxifene metabolite desmethylarzoxifene

A. Lykkesfeldt, G. L. Christensen, Cecilie T Freddie, 2004, Molecular and Cellular Endocrinology.

Regulation of Pancreatic α-Cell Function and Proliferation by Bone Morphogenetic Protein 4 (BMP4) In Vitro.

J. Holst, N. Billestrup, G. L. Christensen, 2016, Endocrinology.

Bone morphogenetic proteins in inflammation, glucose homeostasis and adipose tissue energy metabolism.

S. Vukicevic, T. Schulz, L. Grgurevic, 2016, Cytokine & growth factor reviews.

Ionizing Radiation Potentiates High-Fat Diet–Induced Insulin Resistance and Reprograms Skeletal Muscle and Adipose Progenitor Cells

M. Aznar, L. Specht, Vibe Nylander, 2016, Diabetes.

Predicting Kinase Activity in Angiotensin Receptor Phosphoproteomes Based on Sequence-Motifs and Interactions

L. Jensen, S. Gammeltoft, H. Horn, 2014, PloS one.

Beta-cell dysfunction induced by non-cytotoxic concentrations of Interleukin-1β is associated with changes in expression of beta-cell maturity genes and associated histone modifications

N. Billestrup, M. Sander, P. Thams, 2019, Molecular and Cellular Endocrinology.

Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes

S. Gammeltoft, J. L. Hansen, S. Sheikh, 2011, British journal of pharmacology.

Inhibition of beta cell growth and function by bone morphogenetic proteins

N. Billestrup, T. Mandrup-Poulsen, P. Jensen, 2014, Diabetologia.

Hair Cortisol Concentration, Weight Loss Maintenance and Body Weight Variability: A Prospective Study Based on Data From the European NoHoW Trial

B. Heitmann, J. Turicchi, R. O’Driscoll, 2021, Frontiers in Endocrinology.

Sequential Versus Combined Treatment of Human Breast Cancer Cells with Antiestrogens and the Vitamin D Analogue EB1089 and Evaluation of Predictive Markers for Vitamin D Treatment

I. Christensen, A. Lykkesfeldt, G. L. Christensen, 2004, Breast Cancer Research and Treatment.

CRFR1 activation protects against cytokine-induced β-cell death.

W. Vale, N. Billestrup, T. van der Meulen, 2014, Journal of molecular endocrinology.

Quantitative Phosphoproteomics Dissection of Seven-transmembrane Receptor Signaling Using Full and Biased Agonists*

S. Gammeltoft, J. Olsen, C. D. Kelstrup, 2010, Molecular & Cellular Proteomics.

Upwards Drift of Cerebrospinal Fluid Amyloid-β 42 Over Twelve Years in a Consecutive Clinical Cohort.

G. Waldemar, S. Hasselbalch, A. Simonsen, 2021, Journal of Alzheimer's disease : JAD.

AT1 receptor Gαq protein-independent signalling transcriptionally activates only a few genes directly, but robustly potentiates gene regulation from the β2-adrenergic receptor

S. Gammeltoft, S. Knudsen, J. L. Hansen, 2011, Molecular and Cellular Endocrinology.

AT 1 receptor G q protein-independent signalling transcriptionally activates only a few genes directly , but robustly potentiates gene regulation from the β2 Adrenergic receptor

S. Knudsen, J. L. Hansen, S. Sheikh, 2018 .

Beta cell dysfunction induced by bone morphogenetic protein (BMP)-2 is associated with histone modifications and decreased NeuroD1 chromatin binding

M. Larsen, N. Billestrup, M. Sander, 2023, Cell death & disease.

Characterization of the Molecular Mechanisms Underlying Glucose Stimulated Insulin Secretion from Isolated Pancreatic (cid:2) -cells Using Post-translational Modification Specific Proteomics (PTMomics)*

Taewook Kang, G. L. Christensen, Honggang Huang, 2020 .

Characterization of the Molecular Mechanisms Underlying Glucose Stimulated Insulin Secretion from Isolated Pancreatic β-cells Using Post-translational Modification Specific Proteomics (PTMomics)

G. L. Christensen, Honggang Huang, Martin R. Larsen, 2017 .